Form 4 for ANVS Annovis Bio, Inc.
Accepted 2021-10-13 00:00:00 ET · period of report 2021-10-11 · accession 0001415889-21-004862 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-13 | 2021-10-11 | ANVS | Maccecchini Maria-Luisa | Pres AND CEO, Dir, 10% | P - Purchase | $27.61 | +18.0K | 976.8K | +2% | +$497.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-11 | P | A | 18,000 | $27.61 | 976,775 | D | — | — | (F1) The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.58 to $27.64, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. |